Berberine Ameliorates Insulin Resistance by Inhibiting IKK/NF-κB, JNK, and IRS-1/AKT Signaling Pathway in Liver of Gestational Diabetes Mellitus Rats
- 1 October 2022
- journal article
- research article
- Published by Mary Ann Liebert Inc in Metabolic Syndrome and Related Disorders
- Vol. 20 (8), 480-488
- https://doi.org/10.1089/met.2022.0017
Abstract
Introduction: Berberine is derived from rhizoma coptidis, a well-known Traditional Chinese herbal Medicine that has been found to be effective in the treatment of type 2 diabetes mellitus in recent years. The aim of the present study was to investigate the effects of berberine on a gestational diabetes mellitus (GDM) rat model and the related mechanisms. Methods: GDM was induced in Sprague–Dawley rats using a high-fat diet before and during pregnancy. Berberine (100 mg/kg/day) was administered from the 7th to 20th day of pregnancy. Insulin resistance (IR), glucose tolerance, and maternal, fetal, and placental weight were determined. Liver histopathological analysis, as well as analysis of C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), inhibitor kappa B kinaseβ (IKKβ), nuclear factor kappa-B (NF-κB), c-Jun N-terminal kinase (JNK), insulin receptor substrate-1 (IRS-1), and protein kinase B (AKT), was performed at the end of pregnancy. Results: Treatment of GDM rats with berberine markedly decreased IR, the number of dead and absorptive fetuses, maternal body weight gain, and fetal and placental weight compared with GDM without berberine. Furthermore, berberine decreased CRP and TNF-α levels, IKKβ expression, NF-κB P65 nuclear translocation, and changed the phosphorylation of JNK, IRS-1, and AKT in the liver of GDM rats. Conclusions: Berberine improved IR and maternal–fetal outcomes of GDM rats, possibly through modulation of IKK/NF-κB, JNK, and IRS-1/AKT signaling pathways in the liver. Therefore, berberine may be a potential GDM treatment.Keywords
This publication has 29 references indexed in Scilit:
- Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studiesBiochemistry and Cell Biology, 2015
- Each Degree of Glucose Intolerance in Pregnancy Predicts Distinct Trajectories of β-Cell Function, Insulin Sensitivity, and Glycemia in the First 3 Years PostpartumDiabetes Care, 2014
- Effects of Berberine in the Gastrointestinal Tract — A Review of Actions and Therapeutic ImplicationsThe American Journal of Chinese Medicine, 2014
- Fucosylated Chondroitin Sulfate from Sea Cucumber in Combination with Rosiglitazone Improved Glucose Metabolism in the Liver of the Insulin-Resistant MiceBioscience, Biotechnology, and Biochemistry, 2013
- Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic ratsJournal of Endocrinology, 2013
- The expression of genes involved in NF-κB activation in peripheral blood mononuclear cells of patients with gestational diabetesActa Endocrinologica, 2013
- Insulin receptor and IRS-1 co-immunoprecipitation with SOCS-3, and IKKα/β phosphorylation are increased in obese Zucker rat skeletal muscleLife Sciences, 2012
- Gestational diabetes mellitus: risks and management during and after pregnancyNature Reviews Endocrinology, 2012
- A Research on the Erupted Fetal Diseases Caused by Traditional Chinese Drugs — Discussion from the Issue that Chinese Goldthread Rhizome is Prohibited in SingaporeJournal of Traditional Chinese Medicine, 2008
- The JNK pathway as a therapeutic target for diabetesEmerging Therapeutic Targets, 2005